Skip to Content
800-533-8762
  • Careers
  • Newsroom
  • Health Care Professionals
  • About Us
  • Contact Us
UPMC
  • Find a Doctor
  • Services
    • Frequently Searched Services
    • Frequently Searched Services
      Allergy & Immunology Behavioral & Mental Health Cancer Ear, Nose & Throat Endocrinology Gastroenterology Heart & Vascular Imaging Neurosciences Orthopaedics
      Physical Rehabilitation Plastic & Reconstructive Surgery Primary Care Senior Services Sports Medicine Telemedicine Transplant Surgery Walk-In Care Weight Management Women’s Health
      See all Services
    • Services by Region
    • Find a UPMC health care facility close to you quickly by browsing by region.
      UPMC in Western Pa. Western Pa. and New York
      UPMC in Central Pa. Central Pa.
      UPMC in North Central Pa. North Central Pa.
      UPMC in Western Md. Maryland & West Virginia
    • See All Services
  • Locations
    • Locations by Type
    • Locations by Type
      UPMC hospitals
      Hospitals
      Physical Therapy
      Physical Therapy
      Urgent care
      Walk-In Care
      UPMC Outpatient Centers
      Outpatient Centers
      UPMC Imaging Services
      Imaging
      Community Health Centers
      Community Health Centers
      See All Locations
    • Locations by Region
    • Locations by Region
      UPMC in Southwest Pa. Southwest Pa.
      UPMC in North Central Pa. North Central Pa.
      UPMC in Northwest Pa and Ny. Northwest Pa. & Western N.Y.
      UPMC in West Central Pa. West Central Pa.
      UPMC in Central Pa. Central Pa.
      UPMC in Western Md. Maryland & West Virginia
    • See All Locations
  • Patients & Visitors
    • Patient & Visitor Resources
    • Patient & Visitor Resources
      Patients and Visitors Resources Pay a Bill Classes & Events Medical Records Health Library Patient Information
      Patient Portals Privacy Information Shared Decision Making Traveling Patients Visitor Information
      Man uses mobile phone
      Pay a Bill
      Nurse reviews medical chart
      Request Medical Records
  • Patient Portals
  • Find Covid-19 updates
  • Schedule an appointment
  • Request medical records
  • Pay a bill
  • Learn about financial assistance
  • Find classes & events
  • Send a patient an eCard
  • Make a donation
  • Volunteer
  • Read HealthBeat blog
  • Explore UPMC Careers
Skip to Content
UPMC
  • Patient Portals
  • For Patients & Visitors
    • Find a Doctor
    • Locations
    • Patient & Visitor Resources
    • Pay a Bill
    • Services
    • More
      • Medical Records
      • Financial Assistance
      • Classes & Events
      • HealthBeat Blog
      • Health Library
  • About UPMC
    • Why UPMC
    • Facts & Stats
    • Supply Chain Management
    • Community Commitment
    • More
      • Financials
      • Support UPMC
      • UPMC Apps
      • UPMC Enterprises
      • UPMC International
  • For Health Care Professionals
    • Physician Information
    • Resources
    • Education & Training
    • Departments
    • Credentialing
  • Careers
  • Contact Us
  • Newsroom
  • UPMC >
  • Media Relations >
  • News Releases >
  • 071421 Patel TRTICI Science
Media Relations
News Releases
Central Pa. News
North Central Pa. News
Contact Us
Experts
Community-Focused News
Media Kits
Media RSS
Media Relations
News Releases
Central Pa. News
North Central Pa. News
Contact Us
Experts
Community-Focused News
Media Kits
Media RSS

Low-Dose Radiotherapy + Immunotherapy Eradicates Cancer

For Journalists

Allison Hydzik
Director, Science and Research
412-647-9975
hydzikam@upmc.edu

Cynthia Patton
Director
412-415-6085
pattonc4@upmc.edu

Want to Make an Appointment or Need Patient Information?
Contact UPMC at

1-800-533-8762.

Go to Find a Doctor to search for a UPMC doctor.

7/14/2021

PITTSBURGH – More doesn’t necessarily mean better—including in cancer treatment. 

 

University of Pittsburgh School of Medicine and University of Wisconsin-Madison scientists report today in Science Translational Medicine that combining targeted radiopharmaceutical therapy with immunotherapy significantly boosts eradication of metastatic cancer in mice, even when the radiation is given in doses too low to destroy the cancer outright. 

 

“We’re excited—with such low doses of radiation, we didn’t expect the response to be so positive,” said lead author Ravi Patel, M.D., assistant professor at Pitt and radiation oncologist at UPMC Hillman Cancer Center. “In clinical trials, we tend to go with the maximum tolerable dose, the idea being that radiation kills the cancer and the more we give, the better. But in this study our concept is different—we’re not trying to destroy the tumor with radiation. We’re trying to trigger the immune system to kill the cancer.”

 

Immunotherapy has revolutionized cancer treatment by helping patients’ immune systems fight off cancer. But some patients develop resistance to current immunotherapies and others have cancers characterized by immunologically “cold” tumors, which evade or suppress the patient’s immune response against his or her cancer. 

 

In these cases, oncologists have found that external beam radiotherapy (EBRT)—where a patient is placed in a carefully calibrated machine that aims a beam of radiation directly at their tumor—can help turn “cold” or resistant tumors into “hot” tumors in which the immunotherapy treatments work better. 

 

EBRT cannot typically be delivered to all tumor sites in patients whose cancer has metastasized—or spread to other parts of their body—because distant tumors can be too small, plentiful and diffuse for the patient to tolerate so much radiation. In those cases, targeted radionuclide therapy can be an option. This treatment approach uses a radioactive element that is linked with a cancer-targeting molecule and given through an intravenous infusion, delivering radiation directly to the cancer cells. 

 

Patel and senior author Zachary Morris, M.D., Ph.D., associate professor of human oncology in the University of Wisconsin School of Medicine and Public Health, and their colleagues designed a study to give mice with immunologically cold metastatic cancers varying doses of targeted radionuclide therapy alongside immunotherapy. 

 

“Because radiation from a targeted radionuclide therapy, if given at too high of a dose or at the wrong time, could kill or damage the tumor-infiltrating immune cells that we ultimately want to destroy these tumors, it was critical to design these studies with a precise understanding of the radiotherapy dose and the time over which this would be emitted in the tumor,” Morris said. 

 

For this, Patel and Morris worked closely with a team of medical physicists led by Bryan Bednarz, Ph.D., professor of medical physics in the University of Wisconsin-Madison. By obtaining serial images of the radiation emitted by a targeted radionuclide therapy, this group was able to determine how much and when radiation would be delivered to a tumor and to other normal tissues.

 

To their surprise, the mice given doses much too low to kill the cancer when given alone were the ones that were cured of these cancers when given together with immunotherapy.

 

Instead of destroying the tumors, Patel said, the low-dose radiation was “stressing cells in the tumor,” stimulating the kind of response that the immune system typically produces to an infection. Boosted by the immunotherapy, the immune cells attacked the cancer cells that had been damaged by the radiotherapy.

 

Additionally, when tumor cells were reintroduced to the mice cured by the combination therapy, they quickly fought them off and did not develop cancer again. 

 

“Treating with low-dose radiotherapy and immunotherapy eradicated their cancer, and it also acted as a sort of anti-cancer vaccine, preventing the mice from getting this type of cancer again,” Patel said. 

 

In addition to the mouse studies, the physician-scientists worked together with David Vail, D.V.M., at the University of Wisconsin School of Veterinary Medicine, and tried the combination of targeted radionuclide therapy and immunotherapy as a treatment in pet dogs who had naturally occurring metastatic cancer. The dogs tolerated this treatment combination well, without toxic side effects.

 

In both animal studies, the researchers used a novel agent that can target nearly any type of cancer, including tumors at any location within the body. This agent was developed by one of the co-authors, Jamey Weichert, Ph.D., professor of radiology at the University of Wisconsin School of Medicine and Public Health, in collaboration with co-author Reinier Hernandez, Ph.D., assistant professor of medical physics at the University of Wisconsin-Madison. A Madison-based start-up company, Archeus Technologies, is now completing studies needed to apply for approval from the U.S. Food & Drug Administration to begin testing this agent in human clinical trials.  

 

“Human clinical trials are needed in order to develop our finding into a new standard of care,” said Patel. “In the meantime, the concept of this approach can be tested in humans now, using approved radiotherapies designed to target specific types of cancer.”

 

Additional authors on this research are Peter Carlson, Joseph Grudinski, Ph.D., Amber M. Bates, Ph.D., Justin C. Jagodinsky, Amy Erbe, Ph.D., Ian R. Marsh, M.S., Ian Arthur, Eduardo Aluicio-Sarduy, Ph.D., Raghavan Sriramaneni, Ph.D., Won Jong Jin, Ph.D., Christopher Massey, Alexander L. Rakhmilevich, M.D., Ph.D., Jonathan W. Engle, Ph.D., Trang Le, D.O., KyungMann Kim, Ph.D., and Paul M. Sondel, M.D., Ph.D., all of the University of Wisconsin-Madison.

 

This research was supported by National Institutes of Health grants K08CA241319-01, 1DP5OD024576-01, U01CA233102, R35CA197078, U54CA232568, TL1TR002375, F30CA250263, T32CA009206, P01CA250972, U54 HD090256 and T32 GM008692.
PHOTO INFO: (click images for high-res versions)

 

Top:

CREDIT: UPMC

CAPTION: Ravi Patel, M.D., assistant professor, University of Pittsburgh School of Medicine, and radiation oncologist at UPMC Hillman Cancer Center.

 

Bottom:

CREDIT: University of Wisconsin

CAPTION: Zachary Morris, M.D., Ph.D., associate professor of human oncology, University of Wisconsin School of Medicine and Public Health.

UPMC
200 Lothrop Street Pittsburgh, PA 15213

412-647-8762 800-533-8762

Patients And Visitors
  • Find a Doctor
  • Locations
  • Pay a Bill
  • Patient & Visitor Resources
  • Disabilities Resource Center
  • Services
  • Medical Records
  • No Surprises Act
  • Price Transparency
  • Financial Assistance
  • Classes & Events
  • Health Library
Health Care Professionals
  • Physician Information
  • Resources
  • Education & Training
  • Departments
  • Credentialing
Newsroom
  • Newsroom Home
  • Inside Life Changing Medicine Blog
  • News Releases
About
  • Why UPMC
  • Facts & Stats
  • Supply Chain Management
  • Community Commitment
  • Financials
  • Supporting UPMC
  • HealthBeat Blog
  • UPMC Apps
  • UPMC Enterprises
  • UPMC Health Plan
  • UPMC International
  • Nondiscrimination Policy
Life changing is...
Follow UPMC
  • Contact Us
  • Website/Email Terms of Use
  • Medical Advice Disclaimer
  • Privacy Information
  • Active Privacy Alerts
  • Sitemap
© 2025 UPMC I Affiliated with the University of Pittsburgh Schools of the Health Sciences Supplemental content provided by Healthwise, Incorporated. To learn more, visit healthwise.org
Find Care
Providers
Video Visit
Portal Login

Chat Keywords List

  • cancel or exit: Stops your conversation
  • start over: Restarts your current scenario
  • help: Shows what this bot can do
  • terms: Shows terms of use and privacy statement
  • feedback: Give us feedback
Continue
Chat with UPMC
RESTART
MENU
CLOSE